For the Inventor, By the Inventor

Enter assignee name

Carthera

USPTO Granted Patents = 12

EPO Patents = 9

Trademarks = 2

Forward Citations = 26

Loading Chart...

Loading Chart...

11 inventors (with patents filed for the assignee):

Michael Canney (7 out of 9 patents)

Alexandre Carpentier (6 out of 16 patents)

Guillaume Bouchoux (6 out of 6 patents)

4. Matthieu Cholvy (5 out of 5 patents)

5. Alexandre Vignot (4 out of 4 patents)

6. Francois Lacoste (3 out of 28 patents)

7. Jean-Yves Chapelon (1 out of 32 patents)

8. Cyril Lafon (1 out of 13 patents)

9. Kévin Beccaria (1 out of 1 patent)

10. Guillaume Godefroy (1 out of 2 patents)

11. Cyril Martin (1 out of 1 patent)

12. François Lacoste (3 patents)

13. Cyril Martin (0 patent)

14. Michael Sean Canney (0 patent)

12 patents: Sort by Forward Citations

1. 12390666 - Method and system for detecting a connection terminal (2025-08-19),

2. 12246194 - Method and system for detecting a fault in acoustic coupling between an ultrasonic device and a tissue to be treated (2025-03-11),

3. 12226660 - Implantable medical device for imaging and/or treatment of brain tissue (2025-02-18),

4. 12048585 - Acoustic window for imaging and/or treatment of brain tissue (2024-07-30),

5. 12029652 - Assembly for imaging and/or treating brain tissue (2024-07-09),

6. 11872413 - Control method for the treatment of brain tissue using an ultrasonic probe and an implanted acoustic window on the cranium (2024-01-16),

7. 11849958 - Surgical kit for use in a craniectomy procedure (2023-12-26),

8. 11738214 - Implantable ultrasound generating treating device for brain treatment, apparatus comprising such device and method implementing such device (2023-08-29),

9. 11517364 - Method and system for detecting a fault in an electrical connection between an ultrasound device and a remote control unit (2022-12-06),

10. 11135455 - Ultrasonic thermal ablation probe (2021-10-05),

11. 10981021 - Method for transiently disrupting a region of the blood-brain barrier of a human (2021-04-20),

12. 8977361 - Apparatus for the treatment of brain affections and method implementing thereof (2015-03-10),

Company Overview

Carthera is a pioneering company based in Paris, specializing in the development of innovative medical devices aimed at enhancing the treatment of neurological disorders. The company focuses on advanced ultrasound technologies to facilitate targeted drug delivery to the brain, aiming to improve therapeutic outcomes for patients with conditions such as brain tumors and neurodegenerative diseases. Carthera's research is rooted in a commitment to transforming patient care through cutting-edge medical solutions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

12 Patents

#329 in Paris

#1,485 in France

#48,209 in the World

Carthera

Forward Citations = 26

11 inventors:

Michael Canney (7 out of 9 patents)

Alexandre Carpentier (6 out of 16 patents)

Guillaume Bouchoux (6 out of 6 patents)

4. Matthieu Cholvy (5 out of 5 patents)

5. Alexandre Vignot (4 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Carthera. Retrieved from https://idiyas.com/company/carthera

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…